Lifecore Biomedical Inc reports results for the quarter ended in February - Earnings Summary

Lifecore Biomedical

01/06/2023 14:32

* Lifecore Biomedical Inc  LFCR.OQ  reported a quarterly
adjusted
loss of 22 cents​​ per share for the quarter ended in February.
The mean expectation of two analysts for the quarter was for a
loss of 13 cents per share.
    * Revenue fell 48% to $27.60 million from a year ago;
analysts
expected $28.00 million. 
    * Lifecore Biomedical Inc's reported EPS for the quarter was
a
loss of 51 cents​.
    * The mean earnings estimate of analysts had fallen by
about 533.3% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Lifecore Biomedical Inc shares had risen by 117.0% this
quarter and gained 26.4% so far this year.
    * The company reported a quarterly loss of $40.19 million.
    * Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data June
1 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Feb. 28 2023      -0.13          -0.22          Missed
 Nov. 30 2022      -0.04          -0.24          Missed
 Aug. 31 2022      -0.13          -0.32          Missed
 May. 31 2022      -0.01          -0.01          Met